The many bulges (gyri) and furrows (sulci) of the human cerebral cortex allow a dramatic enlargement of its surface while minimizing its volume. Approximately two thirds of the entire human cortex is buried in sulcal folds. Cortical folding in the primate begins at the onset of interareal pathway formation. Developmental alteration of folding impacts the largescale organization of the cortex (Magrou et al., 2018) and is associated with intellectual disability and epilepsy (de Juan Romero and Borrell, 2017) .
Folding of the cerebral cortex has fascinated scientists for many years. The understanding of the multifaceted developmental mechanisms underlying cortex folding and their interactions has emerged as a major challenge. In the last decade, significant knowledge has been gained regarding the role of specialized germinal zones and the abundance of basal radial glial progenitors (observed in gyrencephalic species) as well as differential proliferation and genetic regulation in controlling the pattern of cortical folding (reviewed in de Juan Romero and Borrell, 2017) . At later stages, folding has been associated with differential migration rates and adhesion properties of migrating neurons (reviewed in de Juan Romero and Borrell, 2017) . Recently, studies focusing on biophysical mechanisms have emphasized the role of tissue properties that constrain folding. Remarkably, polymer gel models of the human cortex convincingly demonstrate that folding can emerge spontaneously as a result of the mechanics of differential swelling (Tallinen et al., 2014) . Interestingly, innovative 3D human organoid culture systems have extended these results, revealing the role of tissue elasticity and mechanical instability in early stages of cortical folding (Karzbrun et al., 2018) .
Here, the insightful study by the Huttner group (Long et al., 2018) paves the way to bridging the gap between genetics and mechanical models of cortical folding. In their quest to identify ECM components associated with neocortex expansion, the authors screened existing transcriptome data sets and identified a triad of highly expressed ECM molecules in the human developing cortex: Lumican (localized throughout the cortical wall), Collagen I, and HAPLN1 (mostly concentrated in the cortical plate, or CP), collectively called HLC. mRNAs that encode HLC are enriched in the germinal zones, suggesting that they are transported from their site of origin to the CP, possibly engaging dynamic transport in the basal process of radial glial cells (Pilaz and Silver, 2017) .The Huttner group explored the role of the HLC triad on native fetal human cortical tissue using either organotypic slices embedded in Collagen I or free-floating explant cultures. Astonishingly, after 24 hours, the HLC cocktail led to early human neocortex folding, exquisitely documented by real-time imaging. Interestingly, HLC treatment accentuated nascent folds at later developmental stages, provided that the treatment was prolonged. All three ECM components are necessary for inducing a high CP gyrencephalic index (GI): GI failed to increase when HAPLN1 and lumican were replaced by other ECM molecules.
What are the mechanisms underlying HLC action on cortical folding? The authors approached this question by elimination. Firstly, they showed that subsequent to HLC treatment in vitro, there was no change in proliferation rates, and further HLC could induce folding even in the absence of cell proliferation. Secondly, apart from a small increase in the expression of ECM and cell adhesion molecules, gene expression was not significantly impacted by HLC treatment. The authors then turned to other potential ECM-related mechanisms involved in fold formation. Changes in ECM organization impact cell distribution and migration, thereby potentially influencing CP stiffness during HLC-induced folding. Using atomic force microscopy, a powerful tool allowing force measurement at the cellular level, the authors detected a rapid effect of HLC treatment on tissue stiffness: several hours prior to detectable fold formation, there was a relative and sustained increase in CP stiffness on the gyri. HLC treatment also increases stiffness in nascent folds, pointing to the role of ECM-mediated changes in tissue stiffness. Importantly, HLC induces a similar pattern of ECM stiffness as that observed in physiologically forming folds.
The authors further deciphered the key role of Hyaluronic Acid (HA) in HLCinduced folding. HA is a non-sulfated glycosaminoglycan and one of the major components of the ECM that interacts with and is modulated by HAPLN1.
Shortly after HLC treatment, HA and HA synthases (HAS) synthesis is induced in parallel with transient silencing of HYAL2 and 3-two hyaluronidases which degrade HA. This results in a dramatic increase in HA levels in the CP prior to fold formation. Treatment with hyaluronidases or with HAS inhibitors before or after fold formation blocks HLC-induced folding. Importantly, HA degradation also reduces inherent folds that spontaneously formed ex vivo, suggesting that HAdependent mechanisms are relevant for physiological fold maintenance. Interestingly, this is accompanied by a reduction in the level of ECM stiffness of nascent folds, favoring the view that HA levels have an impact on the ability of the ECM to undergo stiffness changes (see Figure 1) .
It is known that accumulation of HA results in weakening of cell anchorage to the ECM, thereby facilitating cell migration. Several HA receptors are involved in this process-in particular, CD168 (also known as Receptor for HA Mediated Motility or RHAMM), which forms links with several protein kinases associated with cell locomotion, including extracellular signal regulated protein kinase (ERK). The authors found that CD168 was expressed at higher levels in the CP of nascent gyri than in that of sulci. They demonstrate that both CD168 and downstream ERK signaling are required for HLC-induced folding; activation of ERK signaling also requires HA. Interestingly, CD168 or ERK inactivation did not alter HLC-induced stiffness, suggesting that HLC-induced tissue stiffness is upstream of CD168/ERK signaling. These two mechanisms may also act independently of each other. These important data demonstrate that HA-induced stiffness and CD168/ERK activation are both required for HLCinduced folding, confirming the central role played by HA in cortical folding.
The work of Long et al. (2018) also reveals that the mechanisms underlying ECM-mediated folding are differentially deployed across species. Immunofluorescence against HAPLN1, lumican, and collagen I reveal significant differences in cortices with different GI values ranging from lissencephalic to the highly convoluted human brain. Of note, HAPLN1 and collagen I are not expressed in the E14.5 mouse and E33 ferret neocortices, whereas they are already expressed at high levels in the CP of human cortex at equivalent stages (i..e, prior to fold formation). Other ECM components involved in plasticity of the visual cortex are differentially expressed in the CP of macaques, marmosets, mice, rabbits, and ferrets (Takahata et al., 2006) . In the mouse and ferret, HLC treatment did not induce fold formation at any developmental stage. In the ferret, HA degradation did not block spontaneous folding at postnatal stages; HLC treatment caused a local increase in ECM stiffness, but this was not translated into morphogenetic folding. These effects may be due to a lack of the appropriate downstream effectors, as CD168 is weakly and equally expressed in the CP of gyri and sulci in this species.
Altogether, these observations suggest human-specific features of ECM composition and role in organizing and translating mechanical and chemical signals during cortical folding. ECM has been shown to be an evolutionary target in the human lineage, specially in the ECM protein domain architecture, where domain gain during ECM evolution appears to be more important in driving human innovation than domain loss (Cromar et al., 2014) . Interestingly, Cromar et al. (2014) show a high degree of conservation between macaque and human compared to other vertebrates. HA sequences have also evolved rapidly on an evolutionary time scale (Csoka and Stern, 2013) with specific features in great apes and in humans. In line with this, primatespecific candidate miRNAs regulating At the early stage of fold formation (GW22), CD168 expression level and stiffness are higher in nascent gyri than in sulci. HA inactivation (degradation or inhibition of synthesis) leads to stiffness decrease in gyri and a marked reduction of native folds. HLC treatment increases stiffness and accentuates native folds. HA and HLC are expressed in CP (not shown). (B) Treatment of early human cortex tissue (before fold formation; GW12) with HLC leads to marked cortical folding over a short 24-hr period, subsequent to a rapid increase in HA level in the CP and increased ERK phosphorylation. HLC-induced folding is blocked upon HA inactivation or inhibition of CD168/ ERK signaling. HA inactivation leads to a reduction of HLC-increased stiffness in the CP gyri. It remains to be determined whether (1) modification in ECM stiffness is required for folding independently of HA increase, and also whether (2) HA and activation of CD168/ERK signaling are sufficient to induce folding.
ECM genes (Arcila et al., 2014) have been identified in the Germinal Zones of the developing primate cortex. These observations and others (Takahata et al., 2006) support the view that ECM expression and properties in the developing cortex are modulated in a primate-specific manner, which may have contributed to the increased brain folding in this lineage.
The two culture systems developed by Long et al. (2018) provide invaluable reductionist models that lack a number of physiologically relevant parameters operating in the in vivo developing cortex, such as compression forces, tension, etc. They nevertheless recapitulate several features of in vivo cortical folding: typical invagination of basal lamina, higher degree of folding in the upper cortical layers, and distinct cell organization in the gyri and sulci. By contrast, the topology and tempo of the CP folds does not appear physiologically relevant, with folding occurring over a 8 to 24 hour period as opposed to weeks or months in the human brain. A recent study based on 3D organoids growing in a confined space has provided improved physiologically relevant mechanical culture conditions (Karzbrun et al., 2018) . However, significant differences in scale and structure may signify other limitations to the use of organoids to study the specific mechanics of cortical folding.
These two in vitro models of cortical folding can be used to study early neurodevelopmental disorders. They recapitulate previously described cortical defects: this was illustrated by the absence of HA increase and fold formation upon HLC treatment of fetal cortices with prenatal methamphetamine exposure (PME), previously known to affect folding. In contrast, early fetal cortices with 2p16.3 microdeletions, which are not known to exhibit folding defects, were able to fold after HLC treatment. More importantly, these models provide causative insight into cortical defects such as those shown by delayed HLC-induced folding of Down syndrome cortices. The deterministic model of cortical folding of the Huttner group goes well beyond mere correlative models and is expected to lead to a radical shift in our understanding of a broad category of neurodevelopmental diseases, paving the way for translational studies.
